Gentherm (THRM -2.28%), a global leader in thermal management and pneumatic comfort technologies for automotive and medical markets, reported results for Q2 FY2025 on July 24, 2025. The period saw GAAP revenue reach $375.1 million, beating analyst expectations by 3.2%. However, adjusted EPS was $0.54, missing the $0.58 consensus. The company reported strong progress in commercial wins, but profit margins tightened and net income (GAAP) dropped sharply due to unfavorable currency movements and input cost pre ...

Core Insights - Gentherm reported second quarter 2025 financial results with delivered revenue of $375 million, including a record for Automotive Climate and Comfort Solutions [1][2] - The company secured over $600 million in new automotive business awards during the quarter, totaling $1 billion year-to-date [1][3] - Full-year guidance for 2025 has been narrowed, with product revenues expected between $1.43 billion and $1.5 billion [5] Financial Performance - Product revenues of $375.1 million decreased by 0.2% from $375.7 million in the prior year, with a 1.6% decrease when excluding foreign currency translation [6] - Automotive revenues decreased by 1.5%, while Medical revenues decreased by 4.8% [6] - Adjusted EBITDA was $45.9 million, representing 12.2% of revenue, down from $49.9 million or 13.3% of revenue in the prior year [6][26] Revenue Breakdown - Automotive Climate and Comfort Solutions revenue increased by 3.8% year-over-year, outperforming S&P Global's light vehicle production report by 10 basis points [6] - The company secured automotive new business awards totaling $620 million, including significant contracts with Ford [6][3] - Revenue from Climate Control Seats was $200 million, showing a slight increase, while Lumbar and Massage Comfort Solutions saw a 14.5% increase [23] Guidance and Strategic Focus - The revised guidance for adjusted EBITDA margin rate is set between 11.7% and 12.5% for the full year 2025 [5] - The company is focused on executing strategic priorities and driving operational efficiencies despite macroeconomic uncertainties [5][3] - Capital expenditures guidance has been reduced to $55 million to $65 million from the previous range of $70 million to $80 million [5] Market Position and Outlook - Gentherm maintains a strong liquidity position with $416 million available, reflecting an increase from the previous year [33] - The company continues to innovate and strengthen customer relationships, contributing to its market leadership in thermal management technologies [3][11] - The overall market sentiment has improved, but the company remains cautious in its operational management due to ongoing uncertainties [5]

Company Overview - Gentherm (NASDAQ: THRM) is a global market leader in innovative thermal management and pneumatic comfort technologies [4] - The company offers automotive products such as Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems [4] - In the medical sector, Gentherm provides patient temperature management systems [4] - The company employs over 14,000 people across 13 countries [4] Financial Performance - Gentherm recorded annual sales of approximately $1.5 billion in 2024 [4] - The company secured $2.4 billion in new business awards in the automotive sector [4] Upcoming Events - Gentherm will report its financial results for the second quarter of 2025 on July 24, 2025 [1] - A conference call to discuss these results will take place at 8 am (ET) on the same day [1]

Core Insights - Gentherm expands its partnership with DUOMED into France, enhancing patient temperature management technologies across Europe [1][2] - DUOMED will distribute Gentherm's full patient temperature management portfolio, including the Astopad and Vytil-branded systems [2] - The partnership aims to leverage DUOMED's strong presence and relationships in Europe to improve healthcare delivery [3][4] Company Overview - Gentherm is a global leader in thermal management and pneumatic comfort technologies, with a diverse product range in automotive and medical sectors [5] - In 2024, Gentherm reported annual sales of approximately $1.5 billion and secured $2.4 billion in new automotive business awards [5] - DUOMED, part of the Palex group, specializes in medical technology sales, consultancy, and support, focusing on high-quality solutions for healthcare professionals [6] Product Insights - The Astopad resistive warming system and Vytil-branded convective warming system are key offerings in the partnership [2] - Early feedback from French clinicians indicates a preference for Vytil blankets due to their superior quality compared to competitors [4] - Vytil products are recognized for their quality, safety, and value, with a focus on usability and innovation [7]

Company Overview - Gentherm is a global market leader in innovative thermal management and pneumatic comfort technologies, with a focus on automotive and medical products [4] - The company recorded annual sales of approximately $1.5 billion in 2024 and secured $2.4 billion in automotive new business awards [4] Upcoming Events - Gentherm will participate in the Baird Global Consumer, Technology & Services Conference on June 4, 2025, featuring a fireside chat with CEO Bill Presley and CFO Jon Douyard [2] - A live audio webcast of the fireside chat will be available, with a replay accessible for 90 days on Gentherm's Investor Relations website [3] - Additional conferences include the Stifel Cross Sector 1x1 Conference on June 3, 2025, and the Wells Fargo Industrials & Materials Conference on June 10, 2025 [5]